Nanologica AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nanologica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11154
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nanologica AB (Nanologica) develops nanoporous silica specializing in materials
technology for clinical and chromatography applications. The company’s proprietary technology NLAB Saga, a nanoporous silica media well-adapted for chromatography is used in analytical columns and for bulk manufacturing applications. Its NLAB Silica technology is used for improved delivery of active pharmaceutical ingredients (APIs) in oral dosage forms. Nanologica’s technology loads the pores in the particles with drug substance and then compresses the particles into tablets that are used for treating spinal injuries and the autoimmune disease amyotrophic lateral sclerosis. It works in collaboration with other research institutions such as Stockholm University and Angstrom Laboratories at Uppsala University. Nanologica is headquartered in Sodertalje, Sweden.

Nanologica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanologica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nanologica AB, Medical Devices Deals, 2012 to YTD 2018 9
Nanologica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nanologica AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Nanologica Enters into R&D Partnership 11
Nanolek Enters Into Agreement With Nanologica To Develop Drugs 12
Licensing Agreements 13
INIM Pharma Enters into Licensing Agreement with Nanologica 13
Nanologica Enters Licensing Agreement with Alcyone Lifesciences 14
Equity Offering 15
Nanologica Raises USD5.8 Million in Rights Offering of Shares 15
Sigrid Therapeutics Spins Out from Nanologica 16
Nanologica AB – Key Competitors 17
Nanologica AB – Key Employees 18
Nanologica AB – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
Mar 31, 2017: Nanologica study published in Nanomedicine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Nanologica AB, Pharmaceuticals & Healthcare, Key Facts 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanologica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanologica AB, Deals By Therapy Area, 2012 to YTD 2018 8
Nanologica AB, Medical Devices Deals, 2012 to YTD 2018 9
Nanologica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nanologica Enters into R&D Partnership 11
Nanolek Enters Into Agreement With Nanologica To Develop Drugs 12
INIM Pharma Enters into Licensing Agreement with Nanologica 13
Nanologica Enters Licensing Agreement with Alcyone Lifesciences 14
Nanologica Raises USD5.8 Million in Rights Offering of Shares 15
Sigrid Therapeutics Spins Out from Nanologica 16
Nanologica AB, Key Competitors 17
Nanologica AB, Key Employees 18

List of Figures
Nanologica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanologica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanologica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nanologica AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nanologica AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Deluxe Corporation:企業の戦略・SWOT・財務情報
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Polyus Gold International Limited:企業の戦略・SWOT・財務情報
    Polyus Gold International Limited - Strategy, SWOT and Corporate Finance Report Summary Polyus Gold International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • JSW Steel Ltd:戦略・SWOT・企業財務分析
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • WPX Energy Inc (WPX):石油・ガス:M&Aディール及び事業提携情報
    Summary WPX Energy Inc (WPX Energy) is an oil and gas company that carries out drilling and exploration activities. The company exploits and develops unconventional properties. It produces natural gas, natural gas liquids and crude oil from non-conventional resources including tight-sands, shale for …
  • Digirad Corp (DRAD)-医療機器分野:企業M&A・提携分析
    Summary Digirad Corp (Digirad) is a medical device company that offers mobile and on-site imaging solutions. The company offers camera products which include ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, and cardius 3 XPO. Its diagnostic services include nuclear cardiology, ultrasound, neu …
  • Golden Dawn Minerals Inc (GOM):企業の財務・戦略的SWOT分析
    Summary Golden Dawn Minerals Inc (Golden Dawn) is a mining and mineral exploration and development company. it offers acquisition, exploration, operations, management, production, and development of gold, uranium, silver, iron, lead, zinc, base metals, precious metals, and mineral resource deposit p …
  • Transdev Group SA:企業の戦略的SWOT分析
    Transdev Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Orascom Construction Ltd (OC):企業の財務・戦略的SWOT分析
    Summary Orascom Construction Ltd (Orascom Construction) is an engineering and construction contracting company which concentrates on large industrial, commercial and infrastructure projects. The company offers services, which include civil engineering works, buildings construction and industrial com …
  • Del Taco Holdings, Inc.:企業の戦略・SWOT・財務情報
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Eisai Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemoth …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Immatics Biotechnologies GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Immatics Biotechnologies GmbH (Immatics) is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs …
  • Air Transport Services Group, Inc.:企業の戦略・SWOT・財務情報
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Latam Airlines Group S.A.:企業の戦略・SWOT・財務分析
    Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report Summary Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Burger-In Oy:企業の戦略・SWOT・財務情報
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • AnGes Inc (4563):医療機器:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Kentucky Power Co:企業の発電所・SWOT分析2018
    Kentucky Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆